The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

6 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
2beta-Substituted analogues of 4'-iodococaine: synthesis and dopamine transporter binding potencies.EBI
University of Oklahoma Health Sciences Center
Erlotinib effectively inhibits JAK2V617F activity and polycythemia vera cell growth.EBI
University of Oklahoma Health Sciences Center
Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.EBI
University of Oklahoma Health Sciences Center
Synthesis, structure-activity relationships, and RARgamma-ligand interactions of nitrogen heteroarotinoids.EBI
University of Oklahoma Health Sciences Center
Synthesis and characterization of heteroarotinoids demonstrate structure specificity relationships.EBI
University of Oklahoma Health Sciences Center
Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.EBI
University of Oklahoma Health Sciences Center